DOYLESTOWN, Pa., July 21 /PRNewswire/ -- Avidas Pharmaceuticals and LaRon Pharma Inc. today announced that they have entered into an agreement for LaRon to co-promote Avidas’ key prescription-only convenience kits, Avidoxy(TM) DK defence kit and Scalacort(TM) DK defence kit. Under the terms of the agreement, LaRon will provide sales support focused on primary care and internal medicine physicians in the United States, while Avidas will continue its sales force specialty focus in dermatology. Avidas will also maintain full marketing rights for each of the products. Specific financial terms of the deal were not disclosed.
The Avidoxy DK defence kit includes Avidoxy (Doxycycline Tablets), a broad spectrum oral antibiotic, in an easy-to-swallow film-coated caplet indicated as adjunctive therapy for severe acne, along with complimentary defence(TM) acne wash, a specially formulated oil- and alcohol-free acne wash with 2% salicylic acid that provides gentle, yet effective, cleansing and exfoliation of skin. Avidoxy DK defence kit also includes complimentary defence(TM) solare SPF 30+, a lightweight, oil-free, non-comedogenic sunscreen rich in anti-oxidants and moisturizers offering the broad spectrum sun protection that is so important for patients with acne.
“We are pleased to add the Avidoxy DK and Scalacort DK defence kits to our product portfolio as we expand on our commitment towards a healthy population,” said Ronnee Adesanya, MD, CEO of LaRon Pharma Inc. “We see this co-promotion as a terrific opportunity to grow our collaboration with Avidas Pharmaceuticals while also allowing us to further meet the needs of patients across the country.”
About Avidas:
About LaRon:
Avidoxy Important Safety Information:
The use of drugs of the Tetracycline class during tooth development (last half of pregnancy, infancy, and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown).
About Acne:
Scalacort Important Safety Information:
Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing’s syndrome, hyperglycemia, and glucosuria in some patients. Conditions which augment systemic absorption include the application of the more potent steroids, use over large surface areas, prolonged use, and the addition of occlusive dressings. Therefore, patients receiving a large dose of a potent topical steroid applied to a large surface area or under an occlusive dressing should be evaluated periodically for evidence of HPA axis suppression by using the urinary free cortisol and ACTH stimulation tests.
About Seborrheic Dermatitis:
Facial and trunk seborrhea is characterized by powdery or greasy scale in skin folds and along hair margins.
Psoriasis is a chronic, non-contagious autoimmune disease which affects the skin and joints. It commonly causes red scaly patches to appear on the skin. The scaly patches caused by psoriasis, called psoriatic plaques, are areas of inflammation and excessive skin production. Skin rapidly accumulates at these sites and takes on a silvery white appearance. Approximately half of the people who have psoriasis have scalp psoriasis.
SOURCE Avidas Pharmaceuticals, LLC
CONTACT: Greg Gironda of Avidas Pharmaceuticals, LLC, +1-267-895-1755,
greggironda@avidaspharma.com; or LaRon Pharma Inc., +1-215-542-2868,
admin@laronpharma.com
Web site: http://www.avidaspharma.com/
